AmyloiDia Sweden AB
559216-2332ActiveDeveloping single-molecule sensitive blood tests for pre-symptomatic Alzheimer's diagnosis.
Biotechnology Companyamyloidia.se
Yleiskatsaus
- 0
- Työntekijät
- 100–149t SEK
- Liikevaihto
- 2019
- Perustettu
Avainpäättäjät
Dr Vladana Vukojević
CEO
@amyloidia.se+46703XXXXXX
Dr Sebastian Wärmländer
Member of the Steering Board
Dr Astrid Gräslund
Chair of the Steering Board
Dr Jüri Jarvet
Member of the Steering Board
+7 lisää yhteystietoja Funnelfeedrissä
Kuvaus
AmyloiDia is an R&D-driven BioMedTech company dedicated to eradicating Alzheimer’s disease through early diagnosis. Their core mission involves translating advanced quantitative analytical methods into clinical healthcare applications. They have invented a novel, minimally invasive blood-based techn...
PRE DIAGNOSTICS AS